Life sciences firm Sartorius is introducing an integrated system for the production and quality control (QC) of autologous cell therapies, addressing ‘structural manufacturing bottlenecks’ that ‘limit scalability and patient access to transformative treatments’ such as CAR-T therapies. The modular E
Skin Analytics raises £15M to expand AI skin cancer detection globally following CE mark for autonomous diagnosis. Now entering new markets beyond the UK.
Accumold, A specialist in micro moulding for medical devices will present its latest innovations at MD&M East 2025 in New York City, from 20–22 May. Visitors to Booth 551 can explore how advanced moulding techniques are enabling smaller, smarter medical components. With over 40 years of experience,
Packaging specialist at Sumitomo (SHI) Demag UK Ashlee Gough examines the latest techniques being deployed to counteract these infringements and different methods to safeguard product and named-brand integrity.
The budget and upcoming reform of the NHS could be the start of new era for medical technology – but to harness its potential we need to get spread and adoption right, says Barbara Harpham, Chair of the Medical Technology Group
After the Autumn 2024 budget was announced, MTI reached out to contacts in MedTech for comment on what it would mean for the industry, as well as being inundated with comments from the wider life sciences sector.
Andreas Montag, business development director Medical at Sumitomo (SHI) Demag and regional sales director Andrew Sargisson discuss what’s driving the growth in the cleanroom markets.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags the regulations that herald a new Post-Market Surveillance regime for Medical Devices in the UK.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation encourages the MedTech sector to engage with the latest Cabinet Office consultation on soon to be implemented procurement guidelines.
Jane Hanford explores how the evolution of high-quality ultrasound and imaging innovation, particularly SMI technology, is helping sonographers to identify potential risks early on, and in doing so – allow for more effective treatment options.
